Plasma Cell Cancer | Multiple Myeloma, Pathophysiology, Clinical Features, Investigation /Treatment Plasma Cell Cancer | Multiple Myeloma, Pathophysiology, Clinical Features, Investigation/Treatment #plasmacelldisorder #multiplemyeloma #usmlestep1 #usmlestep2ck In this video I have discussed what are plasma cells and how does plasma cell cancer produce monoclonal immunoglobulins .What is the pathophysiology of multiple myeloma how they cause osteolytic […]

An All Oral Treatment for Multiple Myeloma? Richard Labotka, MD, hematologist-oncologist at the University of Illinois Hospital talks about the latest results from the TOURMALINE-MM2 study presented at ASH 2020. TOURMALINE-MM2 compared the oral treatment regimen of ixazomib, lenalidomide, and dexamethasone to placebo, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma. Multiple myeloma […]

Can myeloma be monitored using only blood testing? In this week’s #AskDrDurie multiple myeloma expert Dr. Brian G.M. Durie discusses if blood testing can accurately monitor the disease. The BOTTOM LINE: While bone marrow biopsy is still needed at initial diagnosis, blood testing is becoming a simple and accurate way to monitor myeloma. _______________ Improving […]

Multiple myeloma: Colin Powell treated for blood cancer prior to his death Despite getting vaccinated against COVID-19, Colin Powell remained vulnerable to the virus because of his advanced age and history of cancer.

Testing for Newly Diagnosed Plasma Cell Myeloma To assist in the care of patients with newly diagnosed plasma cell myeloma, Mayo Medical Laboratories offers two tests that can help with plasma cell clonality determination and proliferation rate as well as targeted genetic analysis. Providing a high-level overview of this testing is Dr. Kaaren Reichard, Senior […]

Optimal treatment sequencing in multiple myeloma Guy Pratt, MD, FRCP, FRCPath, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, discusses treatment sequencing in multiple myeloma, underlining the importance of selecting the best available treatment in first line. Multiple lines of evidence have demonstrated that a patient’s duration of response (DOR) decreases after the first line […]

Pursue 18 E (Live): Plasma Cell Neoplasms : The ABC of Myeloma Pursue 18 E (Live): Hematology – Malignant Lymphoid & Plasmacytic Diseases Plasma Cell Neoplasms: General Considerations. Classification . The ABC of Myeloma Lecture conducted by: Dr Manasi Mundada MD, DNB(Pathology) Consultant Pathologist, Basavatarakam Indo –American Cancer Hospital & Research Centre, Hyderabad Areas of […]

Understanding Treatment Planning in Multiple Myeloma Rafael Fonseca, MD; Gareth Morgan, MD, PhD; and Thomas G. Martin, MD, highlight the importance of treatment planning at all stages in the continuum of multiple myeloma.

Causes of Multiple Myeloma | Dr. Sainath Bhethanabhotla | CARE Hospitals, Banjara Hills What are the risk factors and causes for multiple myeloma and the age factor who are at risk of Multiple Myeloma discussed by Dr. Sainath Bhethanabhotla from CARE Hospitals, Banjara Hills. #CAREHospitals #TransformingHealthcare #MultipleMyeloma #BloodCancer #Cancer #plasmacancer To know more about Dr. […]

Multiple Myeloma: Past, Present and Future Presented By: Kareem Azab, PhD Speaker Biography: Prof. Azab earned a Pharmacy degree (2000), MSc in Medicinal Chemistry (2003) and a Ph.D. in Pharmaceutical Sciences (2007) from The Hebrew University of Jerusalem, and completed post-doctoral training focusing on biology of hematologic malignancies at Harvard Medical School/Dana-Farber Cancer Institute in […]